Caudill, Marissa M; Hunter, Aimee M; Cook, Ian A et al. (2015) The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder. Clin EEG Neurosci 46:277-84
|
Hunter, A M; Leuchter, A F; Cook, I A et al. (2010) Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment. Acta Psychiatr Scand 122:461-9
|
Kalechstein, Ari D; De la Garza 2nd, Richard; Newton, Thomas F et al. (2009) Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci 21:254-8
|
Leuchter, Andrew F; Cook, Ian A; Hunter, Aimee et al. (2009) Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence. Clin EEG Neurosci 40:78-83
|
Leuchter, Andrew F; Cook, Ian A; DeBrota, David J et al. (2008) Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clin EEG Neurosci 39:175-81
|
Cook, Ian A; Bookheimer, Susan Y; Mickes, Laura et al. (2007) Aging and brain activation with working memory tasks: an fMRI study of connectivity. Int J Geriatr Psychiatry 22:332-42
|
Morgan, Melinda L; Cook, Ian A; Rapkin, Andrea J et al. (2007) Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas 56:54-60
|
Venneman, Sandy; Leuchter, Andrew; Bartzokis, George et al. (2006) Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition. J Neuropsychiatry Clin Neurosci 18:208-16
|
Hunter, Aimee M; Leuchter, Andrew F; Morgan, Melinda L et al. (2006) Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry 163:1426-32
|
Hunter, Aimee M; Leuchter, Andrew F; Morgan, Melinda L et al. (2005) Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology 30:792-9
|
Showing the most recent 10 out of 35 publications